CEO Salary & Executive Compensation
Moderna MRNA
CEO: Stephane Bancel · Biotechnology · 5,700 employees
Stephane Bancel, CEO of Moderna (MRNA), earned $9.7M in total compensation in 2025. Moderna receives a Pay-for-Performance grade of A (96/100), with a CEO-to-worker pay ratio of 77:1 and a say-on-pay shareholder approval of 85.6%. The company's 3-year total shareholder return is +584.1%.
How Moderna CEO Pay Compares
Stephane Bancel's $9.7M total compensation is 19% below the Biotechnology industry median of $12.0M. The 77:1 CEO-to-worker pay ratio is 16% lower than the industry average of 92:1.
Moderna (MRNA) disclosed $9.7M in CEO compensation for Stephane Bancel. The package is structured for retention plus performance alignment, with equity awards taking the largest share.
The CEO-to-median-worker pay ratio runs 77x. Lower ratios typically reflect companies with higher-paid workforces (financial services, technology, professional services) where the median worker pay denominator is itself substantial. Performance over the same three-year window has been strong: Moderna delivered a 3-year total shareholder return of 584.1% on top of 389.7% revenue growth. Pay packages of this size are easier to defend when the underlying performance is delivering.
Shareholders supported the compensation package at 86% on the most recent say-on-pay vote. Solid support without overwhelming endorsement is the typical pattern for established public companies with conventional compensation programs. Moderna operates in Biotechnology with 5,700 employees and $6.7B in annual revenue, and currently carries a market capitalization of $35.0B. Pay comparisons across companies require controlling for these structural factors — a $20M package at a $10B-revenue tech company reads differently than the same package at a $1B-revenue industrial.
Source: SEC EDGAR — DEF 14A proxy statements for Moderna (MRNA).
Compensation Breakdown
Stephane Bancel's $9.7M total compensation package for fiscal year 2025 includes $966K in base salary, $4.8M in stock awards, $1.2M in option awards, and $1.4M in bonus and non-equity incentives.
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $966K | - | $4.8M | $1.2M | $1.4M | $1.1M | $9.7M |
| 2024 | $858K | - | $4.3M | $1.0M | $1.3M | $944K | $8.6M |
| 2023 | $800K | - | $4.0M | $960K | $1.2M | $880K | $8.0M |
| 2022 | $800K | - | $4.0M | $960K | $1.2M | $880K | $8.0M |
All compensation data is sourced from SEC DEF 14A proxy filings submitted to EDGAR. The Economic Policy Institute's CEO pay analysis provides additional context on executive compensation trends across industries.
Named Executive Officers
Peer CEO Compensation
Stephane Bancel, CEO of Moderna (MRNA), earns $9.7M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Frequently Asked Questions
Stephane Bancel, CEO of Moderna (MRNA), earns $9.7M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Moderna has a Pay-for-Performance Score of A (96/100). The company's 3-year total shareholder return is +584.1%, and the say-on-pay shareholder vote passed with 85.6% approval.
The CEO-to-median-worker pay ratio at Moderna is 77:1. The median worker at Moderna earns $125K per year, while CEO Stephane Bancel earns $9.7M in total compensation.
Moderna employs approximately 5,700 people. The company operates in the Biotechnology industry within the Healthcare sector, generating $6.7B in annual revenue.